NPI registry status
Active
2026 NPPES data Rheumatology Physician NPI 1831318583 M.D.
Verify on CMS → Jazibeh Qureshi, M.D.
Rheumatology Physician in Catonsville, Maryland.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,377 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 385 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
84%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$3.4K
166 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Jazibeh Qureshi, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 2,673 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 3K
- Part D claims, 2024
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jazibeh Qureshi, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1831318583), first enumerated 04/24/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,673 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$3.4K in reported industry payments (166 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1831318583 · Rheumatology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1831318583
- ENUM-MID 2007
- TAX-MID 6K Rheumatology Physician
- MIPS-NEUTRAL 75/100
- RX-MID 2,673
- BOOK-THIN 184 in Maryland
- PHOTO-ENUM Ailda Nika · 2007
Jazibeh Qureshi, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,673 ≥ 87th percentile 87% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Jazibeh Qureshi, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jazibeh Qureshi, M.D.?
CMS neutral score, not measuredPrimary specialty
Rheumatology Physician
Medicare Part D claims
2,673 30% vs specialty avg
MIPS final score
75/100
Specialty distribution in Maryland
How Rheumatology Physician compares to other specialties among Maryland providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1831318583 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/24/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jazibeh Qureshi, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$3.4K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Jazibeh Qureshi, M.D. - brand share 15.0%
Rheumatology Physician average
15% brand-name claims vs 84% generic, on 2,673 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,673
Total Claims
$2.7M
Total Drug Cost
385
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 5,192.067
- Total Day Supply
- 152,637
- Brand vs Generic
- 15% brand / 84% generic
- Brand Drug Cost
- $2.6M
- Generic Drug Cost
- $88K
- Opioid Claims
- 70 (2.6% rate)
- Antibiotic Claims
- 24
Patient Demographics
- Average Patient Age
- 70.3 years
- Avg HCC Risk Score
- 1.40
- Gender Split
- 85% female / 15% male
- Age Distribution
- <65: 82, 65-74: 168, 75-84: 113, 85+: 22
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jazibeh Qureshi, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
390 claims
- Methotrexate
Methotrexate
348 claims
- Duloxetine Hcl
Duloxetine Hcl
220 claims
- Gabapentin
Gabapentin
175 claims
- Prednisone 142
Prednisone
142 claims
- Leflunomide 111
Leflunomide
111 claims
- Pregabalin 88
Pregabalin
88 claims
- Humira(Cf) Pen 72
Humira(Cf) Pen
72 claims
| Drug | Claims |
|---|---|
| Hydroxychloroquine Sulfate | 390 |
| Methotrexate Methotrexate Sodium | 348 |
| Duloxetine Hcl | 220 |
| Gabapentin | 175 |
| Prednisone | 142 |
| Leflunomide | 111 |
| Pregabalin | 88 |
| Humira(Cf) Pen Adalimumab | 72 |
| Tramadol Hcl | 66 |
| Allopurinol | 63 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Jazibeh Qureshi, M.D. fits within the Rheumatology Physician landscape nationally.
6,377
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,058
Avg Claims per Provider
Jazibeh Qureshi, M.D.'s 2,673 claims are above the specialty average of 2,058.
Nationwide Rheumatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Qureshi, both outside Maryland so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Rheumatology Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as Qureshi.
One of 184 Rheumatology Physician providers enrolled in Maryland, 5 are shown here.
Dr. Jonathan Adelson
M.D.
Greenbelt, MD
Dr. Naila Ahmad
MD
Easton, MD
Dr. Grace Ahn
M.D.
Rockville, MD
Dr. Ashika Ajitkumar
MD
Baltimore, MD
Dr. Maria Alba-Dauhajre
MD
Silver Spring, MD
Compare Rheumatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jazibeh Qureshi, M.D.'s specialty? ▼
Jazibeh Qureshi, M.D. specializes in Rheumatology Physician and practices in Catonsville, Maryland. Credentials: M.D..
How much does Jazibeh Qureshi, M.D. prescribe under Medicare Part D? ▼
In 2024, Jazibeh Qureshi, M.D. wrote 2,673 Medicare Part D claims totaling $2.7M in drug costs for 385 beneficiaries.
What is Jazibeh Qureshi, M.D.'s Medicare quality score? ▼
Jazibeh Qureshi, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jazibeh Qureshi, M.D. located? ▼
Jazibeh Qureshi, M.D. is located at 724 MAIDEN CHOICE LN STE 201, Catonsville, MD, 21228. Phone: (410) 650-4121.
What is Jazibeh Qureshi, M.D.'s NPI number? ▼
Jazibeh Qureshi, M.D.'s National Provider Identifier (NPI) is 1831318583, issued on 04/24/2007.
Does Jazibeh Qureshi, M.D. prescribe more brand-name or generic drugs? ▼
Jazibeh Qureshi, M.D.'s prescribing is 15% brand-name and 84% generic drugs by claim count, with $2.6M in brand drug costs.
Does Jazibeh Qureshi, M.D. prescribe opioids? ▼
Yes, Jazibeh Qureshi, M.D. had 70 opioid claims in 2024 with an opioid prescribing rate of 2.6%.
How many Rheumatology Physician providers are there in the US? ▼
There are 6,377 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,058 Medicare Part D claims per year.
What drugs does Jazibeh Qureshi, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Jazibeh Qureshi, M.D.'s most frequently prescribed drugs include Hydroxychloroquine Sulfate, Methotrexate, Duloxetine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jazibeh Qureshi, M.D. accept Medicare? ▼
Jazibeh Qureshi, M.D. appears in CMS Medicare data with 2,673 Part D claims and 385 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jazibeh Qureshi, M.D.'s credentials? ▼
Jazibeh Qureshi, M.D.'s NPI is 1831318583 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.